Company profile
Twentyeight-Seven Therapeutics company profile
Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.The company's modulating RNA which are short non-coding RNAs that inhibit target gene expression by suppressing mRNA translation and promoting mRNA decay and develop small molecules that can modulate levels of miRNAs by targeting proteins that interact with these miRNAs, enabling users to target miRNAs are directly involved in cancer initiation, progression, and metastasis.
Business identity
- Phone number
- 617-331-7523
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Primghar, Iowa, United States
- Postal code
- 02139
- Country code
- US
- Continent
- North America